Benzodiazepine Selection for Hospital Anxiety

Pharmacokinetic Profiles

Lorazepam has a favorable pharmacokinetic profile, with an onset of action of 15-20 minutes and a duration of 8-15 hours, making it suitable for hospital anxiety management 1, 2
Midazolam has a faster onset of 2-5 minutes but a shorter duration of 3-11 hours, and its active metabolites may accumulate with prolonged administration, especially in patients with renal dysfunction 1, 2
Diazepam has a quick onset of 2-5 minutes but a very long duration of 20-120 hours, and its active metabolites can prolong sedation, especially in patients with renal failure 1, 2

The American College of Critical Care Medicine recommends lorazepam as the preferred benzodiazepine for hospital anxiety due to its predictable duration of action and lack of active metabolites 1, 2
Elderly patients are more sensitive to benzodiazepine effects and should be given lower doses 1
Patients with hepatic dysfunction have reduced clearance of benzodiazepines, and those with renal dysfunction may accumulate active metabolites of midazolam and diazepam, making lorazepam a safer choice 1
Benzodiazepines can cause respiratory depression and systemic hypotension when administered with other cardiopulmonary depressants, particularly opioids 1, 2

Overlooking renal function can lead to accumulation of active metabolites of midazolam and diazepam, making lorazepam safer in patients with renal dysfunction 1
Inadequate monitoring can result in respiratory depression, especially in patients with baseline respiratory insufficiency 1, 2
Parenteral formulations of lorazepam contain propylene glycol, which can cause metabolic acidosis and acute kidney injury 1